0001445064-15-000090.txt : 20150514 0001445064-15-000090.hdr.sgml : 20150514 20150514173417 ACCESSION NUMBER: 0001445064-15-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150513 FILED AS OF DATE: 20150514 DATE AS OF CHANGE: 20150514 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: DAMASTOWN STREET 2: MULHUDDART CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 353 1 8808180 MAIL ADDRESS: STREET 1: DAMASTOWN STREET 2: MULHUDDART CITY: DUBLIN STATE: L2 ZIP: 15 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAILEY DON M CENTRAL INDEX KEY: 0001223697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 15864247 MAIL ADDRESS: STREET 1: 1300 N. KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92607 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-05-13 0001567892 Mallinckrodt plc MNK 0001223697 BAILEY DON M 675 MCDONNELL BLVD. HAZELWOOD MO 63042 1 0 0 0 Ordinary Shares 2015-05-13 4 M 0 51417 26.95 A 191024 D Ordinary Shares 2015-05-13 4 S 0 50017 122.43 D 141007 D Ordinary Shares 2015-05-13 4 S 0 1400 123.18 D 139607 D Stock Options (Right to Buy) 26.95 2015-05-13 4 M 0 51417 0 D 2022-02-15 Ordinary Shares 51417 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 26, 2014. The price represents a weighted average. The shares were sold at prices ranging from $122.02 to $123.00, inclusive. Mr. Bailey will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (3) to this Form 4. The price represents a weighted average. The shares were sold at prices ranging from $123.12 to $123.50, inclusive. Represents options to purchase shares of Questcor Pharmaceuticals, Inc. that were converted into options to purchase ordinary shares of Mallinckrodt plc pursuant to the Agreement and Plan of Merger, dated as of April 5, 2014, by and among Mallinckrodt plc ("Mallinckrodt"), Questcor Pharmaceuticals, Inc. ("Questcor") and Quincy Merger Sub, Inc. All unvested options were accelerated on August 14, 2014 in connection with the acquisition of Questcor by Mallinckrodt. /s/Kenneth L. Wagner, Attorney-in-Fact 2015-05-14